MRES Financials 07/16/2014 09:40:11 Institute of

MRES Financials 07/16/2014 09:40:11
Institute of Biomedical Research Corp.
Period Ending Mar 31, 2014 Mar 31, 2013 Mar 31, 2010
Total Revenue 1,130 522 -
Cost of Revenue 146 70 -
Gross Profit 984 452 -
Operating Expenses
Research and Development 103 113 7
Sales, General and Admin. 178 308 232
Non-Recurring Items - - -
Other 112 28 23
Operating Income 592 4 (273)
Income From Continuing Operations
Add'l Income/Expense Items - - -
Earnings Before Interest and Tax 592 4 (262)
Interest Expense - - 12
Earnings Before Tax 592 4 (273)
Income Tax 68 33 -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations 524 (29) (273)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income 524 (29) (273)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders 524 (29) (273)